查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1709486

患者參與解決方案市場，按組件、按治療領域、按交付模式、按應用、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Patient Engagement Solutions Market, By Component, By Therapeutic Area, By Delivery Mode, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年病患參與解決方案市場規模價值 276.5043 億美元，2025 年至 2032 年的複合年成長率為 21.10%。

患者參與解決方案市場-市場動態

遠距醫療的普及和數位化整合正在改變患者參與解決方案

遠距醫療的採用和數位化整合日益普及，正在改變患者參與解決方案，美國醫學會 (AMA) 報告稱，目前超過 60% 的美國醫療保健提供者使用虛擬護理平台。世界衛生組織 (WHO) 強調了數位健康在提高患者依從性方面的作用，因為行動健康應用程式已顯示慢性病管理成功率提高了 40%。美國《經濟與臨床健康資訊科技法案》（HITECH）等政府措施正在推廣安全的電子健康記錄（EHR）和符合 HIPAA 標準的患者門戶，以提高可訪問性。同時，人工智慧聊天機器人和穿戴式健康設備正在重塑即時病患監測，利用預測分析減少醫院再入院率。隨著基於雲端的平台簡化醫療保健工作流程，產業參與者正在投資人工智慧驅動的解決方案，以進一步增強參與度，確保數位轉型繼續在全球重塑以患者為中心的醫療服務。

病患參與解決方案市場—關鍵見解

根據我們的研究分析師的分析，預計全球市場在預測期內（2025-2032 年）的年複合成長率約為 21.10%。

根據組件細分，預計軟體將在 2024 年佔據最大市場佔有率

根據治療領域細分，慢性病是 2024 年領先的治療領域

根據交付模式細分，雲端交付模式是 2024 年領先的交付模式

按地區分類，北美是 2024 年的主要收入來源

患者參與解決方案市場-細分分析：

全球患者參與解決方案市場根據組件、治療領域、交付模式、應用和地區進行細分。

根據組件，市場分為三類：軟體、服務和硬體。由於 EHR 平台、患者入口網站和 AI 驅動的參與工具的日益普及，軟體引領了市場。隨著實施、培訓和支援需求的不斷成長，服務也隨之而來。硬體佔比較小，主要包括自助服務終端和穿戴式健康設備。

根據治療領域，市場分為兩類：慢性病、健身、女性健康和心理健康。隨著患者參與解決方案增強了對糖尿病和心血管疾病等疾病的管理，慢性病佔據了市場主導地位。心理健康緊隨其後，受到遠距治療採用率不斷提高的推動。受益於行動健康應用程式和穿戴式設備，女性健康和健身佔據較小的佔有率。

患者參與解決方案市場-地理洞察

患者參與解決方案市場正在全球擴張，其中北美由於其強大的醫療保健基礎設施、較高的遠距醫療採用率以及《HITECH 法案》等政府舉措推動數位醫療解決方案而處於領先地位。美國醫療保險和醫療補助服務中心 (CMS) 已經推出了激勵患者參與工具，推動了 EHR 的廣泛整合。歐洲緊隨其後，在通用資料保護規範（GDPR）等監管政策的支持下，確保安全的數位病患互動。亞太地區正在經歷快速成長，中國、日本和印度等國家正在增加對遠距醫療和行動醫療應用的投資，以提高醫療保健的可近性。在拉丁美洲，網路普及率的提高和政府主導的數位健康計畫正在促進市場成長，而中東和非洲則透過智慧醫療計畫和與全球科技公司的合作逐步採用病患參與平台。隨著數位醫療的普及，基礎設施和監管方面的地區差異繼續影響著市場擴張。

病患參與解決方案市場-競爭格局：

患者參與解決方案市場競爭激烈，主要參與者專注於人工智慧驅動的平台、遠距醫療整合和安全資料管理，以增強患者互動。 Epic Systems、Cerner（Oracle Health）和 Allscripts 等領先公司透過廣泛的 EHR 整合和基於雲端的解決方案主導市場。飛利浦、美敦力和通用電氣醫療集團正在投資穿戴式健康技術和用於遠端患者監控的人工智慧分析。 MyChart 和 Welltok 等新興企業透過提供針對個人化醫療客製化的行動參與工具獲得了關注。策略合作，例如微軟與 Nuance 在人工智慧驅動的臨床文件方面的合作，正在進一步重塑該產業。法規遵從性，特別是 HIPAA、GDPR 和 HL7 標準，仍然是一個重點，確保安全處理病患資料。隨著對虛擬護理的需求不斷增加，公司優先考慮可擴展性、互通性和即時患者參與度，加劇了這個快速發展的市場的競爭。

最新動態：

2025 年 2 月，Smart Meter 在 HIMSS 2025 上推出了 SmartHealth Solutions，這是一套旨在提高患者參與度的人工智慧工具。這些解決方案包括慢性病管理應用程式、RTM 步態分析、AI 增強血壓指導、心房顫動監測以及用於患者與提供者互動的 AI 化身，所有這些都旨在改善健康結果。

2024 年 9 月，PatientPoint 推出了 PatientPoint Focus(TM)（現為 Precision(TM)），這是一種可在就診前、就診後和就診期間實現 1:1 患者互動的解決方案。使用可信的溝通管道和同意的 EHR資料，它向患者提供相關的教育內容，使他們能夠與醫生進行更有效的對話，並為他們的健康採取更好的行動。

目錄

第 1 章：患者參與解決方案市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 患者參與解決方案市場片段（按組件）
    • 患者參與解決方案市場片段（按治療領域）
    • 患者參與解決方案市場片段（按交付模式）
    • 患者參與解決方案市場片段（按應用）
    • 患者參與解決方案市場片段（按國家/地區）
    • 患者參與解決方案市場片段（按地區）
  • 競爭洞察

第3章：患者參與解決方案關鍵市場趨勢

  • 患者參與解決方案市場促進因素
    • 市場促進因素的影響分析
  • 患者參與解決方案市場限制
    • 市場限制的影響分析
  • 患者參與解決方案市場機會
  • 患者參與解決方案市場未來趨勢

第4章：病患參與解決方案產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：病患參與解決方案市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：病患參與解決方案市場格局

  • 2024 年病患參與解決方案市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：病患參與解決方案市場 - 按組件

  • 概述
    • 按組件分類的細分市場佔有率分析
    • 軟體
    • 服務
    • 硬體

第 8 章：病人參與解決方案市場 - 按治療領域

  • 概述
    • 按治療領域分類的細分市場佔有率分析
    • 慢性疾病
    • 健康
    • 女性健康
    • 心理健康
    • 其他

第9章：患者參與解決方案市場－按交付模式

  • 概述
    • 按交付方式分類的細分市場佔有率分析
    • 本地部署
    • 基於雲端

第 10 章：患者參與解決方案市場 - 按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 健康管理
    • 家庭健康管理
    • 社會與行為管理
    • 財務健康管理

第 11 章：病患參與解決方案市場 - 按地理分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美患者參與解決方案主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按組件分類）
    • 北美市場規模及預測（按治療領域）
    • 北美市場規模及預測（以交付方式）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲患者參與解決方案主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按組成部分）
    • 歐洲市場規模及預測（按治療領域）
    • 歐洲市場規模及預測（以交付方式）
    • 歐洲市場規模和預測，按應用
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區患者參與解決方案主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（按組成部分）
    • 亞太地區市場規模及預測（依治療領域）
    • 亞太地區市場規模及預測（以交付方式）
    • 亞太地區市場規模及預測（按應用）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲患者參與解決方案主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按組成部分）
    • 拉丁美洲市場規模及預測（按治療領域）
    • 拉丁美洲市場規模及預測（以交付方式）
    • 拉丁美洲市場規模及預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲患者參與解決方案主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（按組件）
    • MEA 市場規模及預測（依治療領域）
    • MEA 市場規模及預測（以交付方式）
    • MEA 市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 12 章：關鍵供應商分析-病患參與解決方案產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Allscripts Healthcare Solutions, Inc.
    • Athenahealth, Inc.
    • Cerner Corporation
    • CureMD Healthcare
    • eClinicalWorks
    • Epic Systems Corporation
    • Get Real Health
    • GetWellNetwork, Inc.
    • IBM Corporation
    • Lincor Solutions Ltd.
    • McKesson Corporation
    • Medecision, Inc.
    • Oneview Healthcare PLC
    • Orion Health Ltd.
    • WelVU
    • YourCareUniverse, Inc.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4959

REPORT HIGHLIGHT

Patient Engagement Solutions Market size was valued at US$ 27,650.43 Million in 2024, expanding at a CAGR of 21.10% from 2025 to 2032.

The Patient Engagement Solutions Market focuses on digital tools and platforms that enhance patient-provider interactions, improve healthcare outcomes, and streamline communication. Increasing adoption of telehealth, with over 40% of U.S. adults using virtual care services, has accelerated demand for these solutions. Government initiatives, such as the CMS Interoperability and Patient Access Rule, are pushing healthcare providers toward integrated engagement platforms. However, data security concerns and interoperability challenges hinder seamless implementation. High initial investment costs also pose barriers for smaller healthcare facilities. Despite these challenges, advancements in AI-driven chatbots and mobile health apps, along with the integration of wearable devices-used by over 30% of global consumers for health monitoring-are creating significant market opportunities. Strategic collaborations between tech companies and healthcare providers are further driving innovation, making patient-centric healthcare more accessible and efficient.

Patient Engagement Solutions Market- Market Dynamics

Rising telehealth adoption and digital integration, transforming patient engagement solutions

Rising telehealth adoption and digital integration are transforming patient engagement solutions, with the American Medical Association (AMA) reporting that over 60% of U.S. healthcare providers now use virtual care platforms. The World Health Organization (WHO) has emphasized digital health's role in improving patient adherence, as mobile health apps have shown a 40% increase in chronic disease management success. Government initiatives, such as the U.S. Health IT for Economic and Clinical Health (HITECH) Act, is promoting secure electronic health records (EHRs) and HIPAA-compliant patient portals to enhance accessibility. Meanwhile, AI-powered chatbots and wearable health devices are reshaping real-time patient monitoring, reducing hospital readmissions by leveraging predictive analytics. As cloud-based platforms streamline healthcare workflows, industry players are investing in AI-driven solutions to further enhance engagement, ensuring that digital transformation continues to reshape patient-centered care globally.

Patient Engagement Solutions Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.10% over the forecast period (2025-2032)

Based on Component segmentation, Software was predicted to show maximum market share in the year 2024

Based on Therapeutic Area segmentation, Chronic Diseases was the leading Therapeutic Area in 2024

Based on Delivery Mode segmentation, Cloud-Based was the leading Delivery Mode in 2024

On the basis of region, North America was the leading revenue generator in 2024

Patient Engagement Solutions Market- Segmentation Analysis:

The Global Patient Engagement Solutions Market is segmented on the basis of Component, Therapeutic Area, Delivery Mode, Application, and Region.

The market is divided into three categories based on Component: Software, Services, and Hardware. Software leads the market due to the rising adoption of EHR platforms, patient portals, and AI-driven engagement tools. Services follow, driven by increasing demand for implementation, training, and support. Hardware holds a smaller share, mainly comprising kiosks and wearable health devices.

The market is divided into two categories based on Therapeutic Area: Chronic Diseases, Fitness, Women's Health, and Mental Health. Chronic Diseases dominate the market as patient engagement solutions enhance management of conditions like diabetes and cardiovascular diseases. Mental Health follows, driven by increasing teletherapy adoption. Women's Health and Fitness hold smaller shares, benefiting from mobile health apps and wearable devices.

Patient Engagement Solutions Market- Geographical Insights

The Patient Engagement Solutions Market is expanding globally, with North America leading due to strong healthcare infrastructure, high telehealth adoption, and government initiatives like the HITECH Act promoting digital health solutions. The U.S. Centers for Medicare & Medicaid Services (CMS) has incentivized patient engagement tools, driving widespread EHR integration. Europe follows closely, supported by regulatory policies such as the General Data Protection Regulation (GDPR), ensuring secure digital patient interactions. The Asia-Pacific region is experiencing rapid growth, with countries like China, Japan, and India increasing investments in telemedicine and mobile health applications to enhance healthcare accessibility. In Latin America, expanding internet penetration and government-led digital health initiatives are fostering market growth, while the Middle East & Africa are gradually adopting patient engagement platforms through smart healthcare projects and collaborations with global tech firms. As digital health adoption rises, regional disparities in infrastructure and regulations continue to shape market expansion.

Patient Engagement Solutions Market- Competitive Landscape:

The Patient Engagement Solutions Market is highly competitive, with key players focusing on AI-driven platforms, telehealth integration, and secure data management to enhance patient interactions. Leading companies like Epic Systems, Cerner (Oracle Health), and Allscripts dominate the market through extensive EHR integration and cloud-based solutions. Philips, Medtronic, and GE Healthcare are investing in wearable health technologies and AI-powered analytics for remote patient monitoring. Emerging players, such as MyChart and Welltok, are gaining traction by offering mobile-based engagement tools tailored for personalized healthcare. Strategic collaborations, such as Microsoft's partnership with Nuance for AI-driven clinical documentation, are further reshaping the industry. Regulatory compliance, particularly HIPAA, GDPR, and HL7 standards, remains a key focus, ensuring secure patient data handling. With increasing demand for virtual care, companies are prioritizing scalability, interoperability, and real-time patient engagement, intensifying competition in this rapidly evolving market.

Recent Developments:

In February 2025, Smart Meter unveils SmartHealth Solutions at HIMSS 2025, a suite of AI-powered tools designed to elevate patient engagement. The solutions include a chronic care management app, gait analysis for RTM, AI-enhanced blood pressure coaching, Afib monitoring, and an AI avatar for patient-provider interactions, all aimed at improving health outcomes.

In September 2024, PatientPoint launched PatientPoint Focus(TM) (now Precision(TM)), a solution enabling 1:1 patient engagement before, after, and between visits. Using trusted communication channels and consented EHR data, it delivers relevant educational content to patients, empowering them to have more effective conversations with their doctors and take better actions toward their health.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Allscripts Healthcare Solutions, Inc.
  • Athenahealth, Inc.
  • Cerner Corporation
  • CureMD Healthcare
  • eClinicalWorks
  • Epic Systems Corporation
  • Get Real Health
  • GetWellNetwork, Inc.
  • IBM Corporation
  • Lincor Solutions Ltd.
  • McKesson Corporation
  • Medecision, Inc.
  • Oneview Healthcare PLC
  • Orion Health Ltd.
  • WelVU
  • YourCareUniverse, Inc.
  • Others

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services
  • Hardware

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Chronic Diseases
  • Fitness
  • Women's Health
  • Mental Health
  • Others

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE- MARKET ANALYSIS, 2019 - 2032

  • On-Premise
  • Cloud-Based

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Health Management
  • Home Health Management
  • Social and Behavioral Management
  • Financial Health Management

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Patient Engagement Solutions Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Patient Engagement Solutions Market Snippet by Component
    • 2.1.2. Patient Engagement Solutions Market Snippet by Therapeutic Area
    • 2.1.3. Patient Engagement Solutions Market Snippet by Delivery Mode
    • 2.1.4. Patient Engagement Solutions Market Snippet by Application
    • 2.1.5. Patient Engagement Solutions Market Snippet by Country
    • 2.1.6. Patient Engagement Solutions Market Snippet by Region
  • 2.2. Competitive Insights

3. Patient Engagement Solutions Key Market Trends

  • 3.1. Patient Engagement Solutions Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Patient Engagement Solutions Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Patient Engagement Solutions Market Opportunities
  • 3.4. Patient Engagement Solutions Market Future Trends

4. Patient Engagement Solutions Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Patient Engagement Solutions Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Patient Engagement Solutions Market Landscape

  • 6.1. Patient Engagement Solutions Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Patient Engagement Solutions Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Services
    • 7.1.4. Hardware

8. Patient Engagement Solutions Market - By Therapeutic Area

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
    • 8.1.2. Chronic Diseases
    • 8.1.3. Fitness
    • 8.1.4. Women's Health
    • 8.1.5. Mental Health
    • 8.1.6. Others

9. Patient Engagement Solutions Market - By Delivery Mode

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Delivery Mode, 2024 & 2032 (%)
    • 9.1.2. On-Premise
    • 9.1.3. Cloud-Based

10. Patient Engagement Solutions Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Health Management
    • 10.1.3. Home Health Management
    • 10.1.4. Social and Behavioral Management
    • 10.1.5. Financial Health Management

11. Patient Engagement Solutions Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Patient Engagement Solutions Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Patient Engagement Solutions Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Patient Engagement Solutions Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Patient Engagement Solutions Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Patient Engagement Solutions Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Patient Engagement Solutions Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Allscripts Healthcare Solutions, Inc.
    • 12.2.2. Athenahealth, Inc.
    • 12.2.3. Cerner Corporation
    • 12.2.4. CureMD Healthcare
    • 12.2.5. eClinicalWorks
    • 12.2.6. Epic Systems Corporation
    • 12.2.7. Get Real Health
    • 12.2.8. GetWellNetwork, Inc.
    • 12.2.9. IBM Corporation
    • 12.2.10. Lincor Solutions Ltd.
    • 12.2.11. McKesson Corporation
    • 12.2.12. Medecision, Inc.
    • 12.2.13. Oneview Healthcare PLC
    • 12.2.14. Orion Health Ltd.
    • 12.2.15. WelVU
    • 12.2.16. YourCareUniverse, Inc.
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us